Loading...

ACAD ACADIA PHARMACEUTICALS INC Management Changes 8-K Filing

CD P

CD

ACADIA PHARMACEUTICALS INC

(ACAD)

2026 8-K

Annual Meeting Results

Financial Results Announcement

Director Appointment

Financial Results Release

Sales Forecast Update

Financial Results Announced

Board Resignation

Financial Statements

Management Changes

Earnings Releases

Bylaw Amendments

Financial Results

Management Change

Q3 Financial Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Results of Phase 3 ADVANCE-...

Financial Results Announcement

Departure of Directors

Management Change

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

Financial Results Announcement

External Links:

On March 3, 2026, Acadia Pharmaceuticals appointed Jonathan M. Poole to its Board of Directors and as a member of the Audit Committee, providing him an annual cash retainer of $62,500, plus equity awards valued at $295,300.

AI Assistant

ACADIA PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.